Hepatitis C News

Administration of direct-acting antiviral agents safely and effectively treated children with hepatitis C, according to a presentation at the International Liver Congress.

Tenofovir reduced the severity of COVID-19 infection among patients with chronic hepatitis B, according to a presentation at The Digital International Liver Congress.

My initial fascination with infectious diseases began as it did for many others: through the influence of my parents and exposure through books.

Under an FDA-approved expansion of the pediatric indication, children as young as age 3 years are now able to receive Epclusa for the treatment of chronic hepatitis C virus regardless of HCV genotype or severity.

Ravidasvir in addition to sofosbuvir was safe and effective in the treatment of patients with chronic hepatitis C virus, according to research published in The Lancet Gastroenterology and Hepatology.

Transplanting organs from donors with hepatitis C virus may increase the number of transplants performed and reduce waitlist times, but the optimal treatment strategy for recipients requires further investigation, according to a speaker.

Groundbreaking developments in HIV treatment are transitioning the disease into a chronic condition. Thankfully, patients can live long and full lives, but other challenges arise, particularly for those living with both HIV and the hepatitis C virus.

A collaborative approach between nephrologists and gastroenterologists led to improvements in the diagnosis and treatment of hepatitis C virus across 31 dialysis facilities in Changhua County, Taiwan.

Efforts to end HIV, viral hepatitis and STIs by 2030 were off-track even before the COVID-19 pandemic struck, according to a new report.

My career has been on the preventing infectious diseases side.